Product image of Beyfortus (Nirsevimab) supplied by GNH India

Beyfortus

Active Ingredient:
Nirsevimab
Origin:
EU

Beyfortus (Nirsevimab)

Beyfortus (Nirsevimab) is a respiratory syncytial virus (RSV) preventive medication administered intramuscularly. It is designed to protect infants and young children from RSV infections, which can cause severe respiratory illness. This medication is manufactured by Sanofi Winthrop Industrie and is available in the EU.

Manufacturer / TM Owner

Sanofi Winthrop Industrie

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Beyfortus is primarily used for the prevention of respiratory syncytial virus (RSV) infections in infants and young children. RSV can lead to severe respiratory illnesses, such as bronchiolitis and pneumonia. This medication is administered intramuscularly and is intended to provide protection during the RSV season. Parents and caregivers often seek Beyfortus to safeguard their children from the potentially serious complications of RSV.

Side Effects

  • Beyfortus is designed to help the immune system recognize and fight off RSV infections. Common effects may include mild reactions at the injection site, such as redness or soreness. Some individuals may experience temporary discomfort or fever following administration. These effects are generally mild and short-lived.

Precautions & Warnings

  • Beyfortus should be administered by healthcare professionals experienced in intramuscular injections. It is important to inform your healthcare provider about any allergies or medical conditions before receiving this medication. Always follow the storage and handling instructions provided with the medication to ensure its effectiveness.

Avoid Interactions

  • There are limited data on drug interactions with Beyfortus. However, it is always advisable to inform your healthcare provider about any other medications or supplements you are taking. This helps in assessing potential interactions and ensuring the safe use of Beyfortus.

Frequently Asked Questions

Beyfortus is used to prevent respiratory syncytial virus (RSV) infections in infants and young children.

Beyfortus is administered intramuscularly by a healthcare professional.

Common effects may include mild reactions at the injection site, such as redness or soreness, and possibly a temporary fever.

Beyfortus is manufactured by Sanofi Winthrop Industrie.

Yes, Beyfortus is available in the EU.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nirsevimab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT